Registered Tanzania · TMDA

ENDOMAX Disinfectant Solution

Glutaraldehyde 2.4 % w/v

TAN 22 AD 0316

What it does

Glutaraldehyde is a chemical used mainly for disinfecting and sterilizing medical equipment.

Commonly used for: disinfecting medical instruments, sterilizing surgical tools

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
TAN 22 AD 0316
Registration date
2022-08-01
Expiry date
2027-07-31
Status
Registered/Compliant
Active ingredient
Glutaraldehyde 2.4 % w/v
Dosage form
-
Strength
-
Pack size
-
Therapeutic class
-
RxNorm RxCUI
4888
Manufacturer / MAH
Tulip Diagnostics
Applicant / LTR
ANUDHA LTD.
Country of origin
INDIA

Source: Tanzania Medicines and Medical Devices Authority · fetched 2026-03-11 23:40:19 · updated 2026-10-19 03:00:44

Disclaimer: This information is sourced from Tanzania Medicines and Medical Devices Authority (Tanzania). Always consult a qualified healthcare professional before using any medication.

About this medicine

Glutaraldehyde is a chemical used mainly for disinfecting and sterilizing medical equipment.

What it treats

  • disinfecting medical instruments
  • sterilizing surgical tools

How it works

It kills bacteria and viruses by breaking down their cellular structures.

Who it's for

This is used by healthcare professionals in hospitals and clinics.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: Glutaraldehyde

BNF-referenced

Glutaraldehyde is a potent disinfectant and antiseptic, widely utilized for its efficacy in sterilizing medical instruments and surfaces. It acts as a cross-linking agent, primarily engaging with amino groups in proteins, which facilitates its application in the treatment of certain dermatological conditions such as warts and calluses. Its effectiveness stems from its ability to inactivate microorganisms, making it valuable in both clinical and laboratory settings.

Indications

  • Warts, particularly plantar warts
  • Condylomata acuminata affecting the penis or female external genitalia
  • Sterilization of medical instruments

Dosage

Children: For children aged 2–17 years (initiated under specialist supervision), apply twice daily for 3 consecutive days. Treatment may be repeated at weekly intervals if necessary for a total of four 3-day courses.

Adults: Apply twice daily to the lesion for up to 3 applications, ensuring to remove dead skin before use. Treatment may be repeated weekly if necessary.

Mechanism of action

Glutaraldehyde functions primarily by cross-linking with proteins and nucleic acids, leading to microbial cell death. This cross-linking interferes with the normal functioning of cellular components, thereby disrupting metabolism and replication in bacteria, viruses, and fungi.

Pharmacodynamics

The pharmacodynamic profile of glutaraldehyde is characterized by its rapid action as a broad-spectrum antimicrobial agent. It exhibits bactericidal, virucidal, and fungicidal properties, making it effective against a wide range of pathogens, including resistant strains. Its activity is influenced by concentration, exposure time, and pH levels, with higher concentrations and longer exposure times enhancing its antimicrobial effects.

Pharmacokinetics

Glutaraldehyde is primarily used topically and does not have significant systemic absorption when applied appropriately. It is rapidly metabolized and eliminated from the body. The exact pharmacokinetic parameters, such as half-life or volume of distribution, are not well characterized due to its topical use and rapid inactivation upon contact with tissues.

Contra-indications

  • Not for application to anogenital areas
  • Not for application to the face
  • Not for application to mucosa
  • Avoid broken skin

Adverse effects

  • Skin irritation
  • Rash
  • Balanoposthitis
  • Severe cutaneous adverse reactions
  • Argyria
  • Methaemoglobinaemia

Precautions

  • Avoid application to normal skin
  • Avoid open wounds
  • Keep away from eyes
  • Use under specialist supervision for children

Pregnancy

Avoid use during pregnancy.

Breast-feeding

Avoid use during breastfeeding.

Storage

Store in a cool, dry place, away from direct sunlight.

Formulations

  • Warticon 0.5% solution
  • Glutaraldehyde liquid
BNF 85 (British National Formulary) p.1427 BNF for Children 2019-2020 p.812 PubChem / pathway

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Molecular reference: Glutaraldehyde

PubChem CID 3485

Molecular formula: C5H8O2

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.